HNSCC cells exhibit basal IL-6 expression driven by the constitutive activation of the NF-κB and STAT3 signaling pathways, while basal IL-8 expression is regulated primarily through the NF-κB pathway (57–59). The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.